MX2020002859A - Composicion para decapoda, que comprende acido 5-aminolevulinico. - Google Patents

Composicion para decapoda, que comprende acido 5-aminolevulinico.

Info

Publication number
MX2020002859A
MX2020002859A MX2020002859A MX2020002859A MX2020002859A MX 2020002859 A MX2020002859 A MX 2020002859A MX 2020002859 A MX2020002859 A MX 2020002859A MX 2020002859 A MX2020002859 A MX 2020002859A MX 2020002859 A MX2020002859 A MX 2020002859A
Authority
MX
Mexico
Prior art keywords
decapod
aminolevulinic acid
composition
orally administered
administered composition
Prior art date
Application number
MX2020002859A
Other languages
English (en)
Inventor
Asuka SUMI
Shin Taniguchi
Ikuo Hirono
Hidehiro Kondo
Ivane PEDROSA-GERASMIO
Kentaro Imaizumi
Original Assignee
Neopharma Japan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharma Japan Co Ltd filed Critical Neopharma Japan Co Ltd
Priority claimed from JP2018168668A external-priority patent/JP2019055943A/ja
Publication of MX2020002859A publication Critical patent/MX2020002859A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente invención se refiere a una composición para administración oral para Decapoda que comprende ácido 5-aminolevulínico (5-ALA), y un método que comprende alimentar ácido 5-aminolevulínico a Decapoda. La composición para administración oral para Decapoda puede ser usada para criar y cultivar Decapoda, y puede prevenir y tratar efectivamente el síndrome de mortalidad temprana/enfermedad de necrosis hepatopancreática aguda (EMS/AHPND) causada por Vibrio parahaemolyticus como una bacteria patogénica. El crecimiento de Decapoda puede ser promovido por administración de una cantidad predeterminada de la composición para administración oral para Decapoda.
MX2020002859A 2017-09-19 2018-09-10 Composicion para decapoda, que comprende acido 5-aminolevulinico. MX2020002859A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017179379 2017-09-19
PCT/JP2018/033494 WO2019059027A1 (ja) 2017-09-19 2018-09-10 ５－アミノレブリン酸を含むエビ目用組成物
JP2018168668A JP2019055943A (ja) 2017-09-19 2018-09-10 ５−アミノレブリン酸を含むエビ目用組成物

Publications (1)

Publication Number Publication Date
MX2020002859A true MX2020002859A (es) 2020-07-24

Family

ID=65810251

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020002859A MX2020002859A (es) 2017-09-19 2018-09-10 Composicion para decapoda, que comprende acido 5-aminolevulinico.

Country Status (3)

Country Link
JP (1) JP7572598B2 (es)
MX (1) MX2020002859A (es)
WO (1) WO2019059027A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3280998A1 (en) 2019-02-13 2025-10-30 Alpheus Medical, Inc. Non-invasive sonodynamic therapy
JPWO2020218577A1 (es) * 2019-04-26 2020-10-29
WO2020243319A1 (en) 2019-05-29 2020-12-03 Sonalasense, Inc. Sonosensitization
CA3185803A1 (en) 2020-08-07 2022-02-10 Vijay Agarwal Ultrasound arrays for enhanced sonodynamic therapy for treating cancer
CN112075551A (zh) * 2020-09-28 2020-12-15 北京挑战农业科技有限公司 一种用于提高水产养殖动物成活率的添加剂及其应用
CN117677300A (zh) 2021-07-09 2024-03-08 住友化学株式会社 十足目的生物的饲养用组合物和针对十足目感染症的预防或治疗用组合物
WO2023180282A1 (en) * 2022-03-24 2023-09-28 Evonik Operations Gmbh Co-precipitates of methionylmethionine with organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100365151B1 (ko) * 2000-05-08 2003-02-11 김형락 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도
KR101468610B1 (ko) * 2013-02-26 2014-12-04 한남바이오 주식회사 갑각류 양식용 사료 조성물

Also Published As

Publication number Publication date
JP7572598B2 (ja) 2024-10-24
JP2023055828A (ja) 2023-04-18
WO2019059027A1 (ja) 2019-03-28

Similar Documents

Publication Publication Date Title
MX2020002859A (es) Composicion para decapoda, que comprende acido 5-aminolevulinico.
JOP20160092B1 (ar) علاج البيتا ثلاسيميا باستخدام مصطبة لجائنية
WO2019199861A3 (en) Hemp extract for treatment of pain in animals
NO20083965L (no) Anvendelse av olivenekstrakt som et pronaeringsstoff i dyrefôr
NZ595585A (en) Animal feed compositions and feeding methods
MX362626B (es) Métodos para tratar pacientes pediátricos usando dexmedetomidina..
MX2022001225A (es) Metodo para mejorar la salud digestiva.
MY203645A (en) Ret inhibitor for use in treating cancer having a ret alteration
ZA202000028B (en) Use of vibegron to treat overactive bladder
ZA201906927B (en) A solid feed combination composition for ruminant calves
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
RU2016119285A (ru) Кормовая добавка и способ ее применения в молочном животноводстве
PH12013500371A1 (en) Therapeutic agent for pain
PH12022550430A1 (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
ES2574999T3 (es) Método para la contracepción a demanda usando levonorgestrel o norgestrel
RU2005104894A (ru) Способ повышения мясной продуктивности молодняка свиней на откорме
AR129925A1 (es) Composiciones agrícolas y métodos
RU2012129115A (ru) Способ лечения острых послеродовых эндометритов у коров
MX2021015590A (es) Metodos y composiciones con beneficios renales para felinos.
RU2011108858A (ru) Средство для повышения роста и сохранности молодняка
RU2009149483A (ru) Способ профилактики опухолевых заболеваний репродуктивных органов кур
Vargas First report of proximal myopathy: case report
Courboulay et al. Effects of piglet age on some indicators assessing pain at tail docking, with or without analgesia
RU2014107146A (ru) Способ профилактики канцерогенного действия диэтилнитрозамина у экспериментальных животных
RU2010122270A (ru) Способ профилактики кетоза у высокопродуктивных молочных коров